| Heading: |
Hormone Treatments: Children |
| Question ID: |
1751840 |
| UIN: |
21512 |
| House: |
Commons |
| Date tabled: |
2024-12-19 |
| Asking Member ID: |
5047 |
| Asking Member display name: |
James Naish
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
James Naish
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, for what reason Gonadotrophin-Releasing Hormone Analogues are permitted for treatment of precocious puberty but not gender incongruence. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-08 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Gonadotrophin-releasing hormone analogues, puberty suppressing hormones, have been licenced by the Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of precocious puberty and certain types of cancer. In granting a licence for th... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |